MIT Sloan logo MIT logo

Research


Financial Orphan Therapies Looking For Adoption

2014
Health Affairs Blog
Vikas Sukhatme, Kathy Fang, Vidula Sukhatme

Open-Source Software for “Financing Drug Discovery for Orphan Diseases”

2014
David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein

Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

2014
JAMA Otolaryngology-Head & Neck Surgery (2014)
Tito Fojo, Sham Mailankody

The Origin of Risk Aversion

2014
Proceedings of the National Academy of Sciences 111(2014), 17777–17782.
Ruixun Zhang, Thomas J. Brennan

Dynamic Loss Probabilities and Implications for Financial Regulation

2014
Yale Journal on Regulation 31(2014), 667–694.
Thomas J. Brennan

Group Selection as Behavioral Adaptation to Systematic Risk

2014
PLOS One 9 (2014)
Ruixun Zhang, Thomas J. Brennan

Parallel Discovery of Alzheimer’s Therapeutics

2014
Science Translational Medicine 241(6), 1-8
Carole Ho, Jayna Cummings, Kenneth S. Kosik

When Do Stop-Loss Rules Stop Losses?

2014
Journal of Financial Markets 18 (2014), 234-254.
Kathryn M. Kaminski

Fear, Greed, and Financial Crises: A Cognitive Neurosciences Perspective

2013

Open-Source Software for “Can Financial Engineering Cure Cancer?”

2013
David E. Fagnan, Jose Maria Fernandez, and Roger M. Stein

© 2020 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.